Jildou Sijbrandij

Cost Analysis and Cost Determinants in a European Inflammatory Bowel Disease Inception Cohort With 10 Years of Follow-up Evaluation

Selwyn Odes, Hillel Vardi, Michael Friger et al. · Gastroenterology · 2006 · 224 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +16

Effect of a practice-based strategy on test ordering performance of primary care physicians: a randomized trial.

Wim Verstappen, Trudy van der Weijden, Jildou Sijbrandij et al. · PubMed · 2003 · 165 citations

Nursing, Family Medicine, Internal Medicine +17

Disease outcome of inflammatory bowel disease patients: General outline of a Europe-wide population-based 10-year clinical follow-up study

Maurice G. Rüssel, Jildou Sijbrandij, Leo J. Schouten et al. · Scandinavian Journal of Gastroenterology · 2006 · 78 citations

Medicine, Health Sciences, Clinical Epidemiology +14

Effect of antitumour necrosis factor‐<i>α</i> therapy on bone turnover in patients with active Crohn's disease: a prospective study

Barbara M. Ryan, M.G.V.M. Russel, Leon J. Schurgers et al. · Alimentary Pharmacology & Therapeutics · 2004 · 69 citations · Full text

Medicine, Immunology, Bone Metabolism +16

Differences in prescribing between GPs. Impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives

Paul E. M. Muijrers, Richard Grol, Jildou Sijbrandij et al. · Family Practice · 2005 · 69 citations

Pharmacy, Community Pharmacy, Pharmacy Practice +8